UK regulator approves "groundbreaking" gene treatment for sickle cell and beta thalassaemia. Wilkinson E. BMJ 2023;383:p2706.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wilkinson E. UK regulator approves "groundbreaking" gene treatment for sickle cell and beta thalassaemia. BMJ 2023;383:p2706.
PMID: 37973171